Curanex Pharmaceuticals CURX
NASDAQ CURX
$4.97 -0.06 (-1.29%)
As of: Sep 29, 2026 · 3:50 PM EDT

Curanex Pharmaceuticals (CURX) Research & Development (2025 - 2026)

Updated

Curanex Pharmaceuticals (CURX) recorded Research & Development of $2.59 million in Q2 2026.

Analysis

Curanex Pharmaceuticals (CURX) Research & Development (2025 - 2026) Analysis & Trends

For FY2025, Curanex Pharmaceuticals reported Research & Development of $2.99 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Curanex Pharmaceuticals 7.25 Mn -6.60 Mn - 2.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.59 Mn
Dec 31, 2025 2.31 Mn
Sep 30, 2025 677,474.00
API Access

Curanex Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=CURX&period=max&api_key=YOUR_API_KEY